Comparable antiviral capacity but favorable in vitro survival of CD8s from elite controllers compared to untreated progressors

• Shasha D,
• Porichis F,
• Daniel K,
• Angiuli O,
• Kaufmann DE,
• Walker B

Affiliations

Shasha D

Porichis F

Daniel K

Angiuli O

Kaufmann DE

Walker B